ArticleJournal of clinical orthopaedics and trauma2025
Clinical outcomes of reverse shoulder arthroplasty in obstetric brachial plexus palsy with suprascapular nerve injury and glenohumeral osteoarthritis.
Article in Journal of clinical orthopaedics and trauma, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Glenohumeral arthrodesis utilizing intraoperative computer navigation: a case report and surgical technique.JSES reviews, reports, and techniques · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Untreated obstetric brachial plexus palsies (OBPP) present with various upper limb impairments, including muscle weakness, soft tissue contractures, and osteoarticular deformities. Reverse shoulder arthroplasty (RSA) medializes the center of rotation, optimizing deltoid function to compensate for deficits caused by OBPP. This study evaluates the effectiveness of RSA in patients with untreated OBPP involving the suprascapular nerve and end-stage glenohumeral osteoarthritis (OA), focusing on functional and quality-of-life improvements. Methods: A retrospective analysis was performed on patients with OBPP involving the suprascapular nerve and end-stage glenohumeral OA who underwent RSA. Included patients had significant deficits in the supraspinatus and infraspinatus muscles but preserved deltoid function. Pre- and postoperative assessments included Range of Motion (ROM), Visual Analog Scale (VAS), and Patient-Reported Outcome Measures (PROMs). Data on complications and revision surgeries were also collected. Results: Seven patients (2 males, 5 females; mean age 38.9 ± 14.9 years) with a median follow-up of 3.1 ± 2.2 years were included. Postoperatively, significant improvements were observed in limb function and quality of life, as reflected in the Constant Shoulder Score (CSS), Oxford Shoulder Score (OSS), and Quick Disabilities of the Arm, Shoulder, and Hand (QDASH). Pain levels decreased markedly, and ROM showed a moderate increase. No complications or revision surgeries were reported. Conclusions: RSA is an effective and safe surgical option for patients with untreated OBPP involving the suprascapular nerve and end-stage glenohumeral OA, yielding significant functional and quality-of-life improvements at short- and mid-term follow-up. The absence of complications and revision surgeries further supports its reliability in this challenging patient population. Level of evidence: IV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.